What do we do
Goals
What is a rare disease?
Little or nothing we know of these diseases called rare, by minority and infrequent. And yet, there are more than 7,000 and any of us can develop them.
The Rare Diseases , including those of genetic origin, are those diseases with danger of death or chronic disability, which have a low frequency or prevalence (less than 5 cases per 10,000 inhabitants), according to the definition of the European Union.
Today, there is a lack of medical response and serious diagnostic problems.
Goals
The ISABEL GEMIO FOUNDATION for the Research of Muscular Dystrophies and other Rare Diseases </ b> directs its efforts initially to the following aspects:
- Financing and promotion of openings of Scientific Research Projects for the study of rare diseases.
- Contribution to the training of researchers and professionals . Essential to offer a correct diagnosis and progress quickly in the study and research of less frequent diseases.
- The integration of tools and knowledge methods that increase the efficiency of the treatments: creation or adaptation of the existing laboratories, creation and maintenance of bio-banks, databases of patients and cataloging of the diseases.
- Dissemination of the research work and general aspects </ b> that may be of interest to affected patients and relatives.
- Support for patient associations, the search for synergies and joint actions with other entities </ b> for similar purposes.
- Attention to those affected and their families within the scope of the Foundation’s competences.
Campaña BIZUM
Manda un BIZUM al 05920 en el apartado donaciones/ONG y dona la cantidad que tu quieras (a partir de 0,50€) a los proyectos de investigación de Enfermedades Raras.
Ayúdanos
Erradicar las enfermedades raras solo es posible con financiación para la investigación. Ayúdanos y obtén un 80% de desgravación sobre tu donación.
Lines of investigation
Thanks to many people we have contributed 1,793,700 to the research lines of the Isabel Gemio Foundation
Our active Scientific Research Lines:
Project Autophagic / lysosomal dysfunction in neuromuscular diseases
DR. JOSÉ MANUEL FUENTES
Center for Biomedical Research in Neurodegenerative Diseases Network (CIBERNED)
Dept. Biochemistry and Molecular Biology and Genetics
Faculty of Nursing and Occupational Therapy
University of Extremadura
NeuroPaisaje-The landscape between phenotype and genotype in neurological diseases of development: validation of a clinical functional biology model
DR. FRANCESC PALAU MARTÍNEZ
Head of the Genetic and Molecular Medicine Service of the Sant Joan de Deu Hospital in Barcelona
Dir. Pediatric Institute of Rare Diseases (IPER)
Therapeutic approaches in muscular dystrophies using cellular and animal models
DRA. ISABEL ILLA
Hospital Santa Cruz and San Pablo de Barcelona
Characterization of cells with myogenic potential
DR. ADOLFO LÓPEZ DE MUNAIN
ILUNDAIN Foundation for Neurological Studies
Donostia Hospital of San Sebastián
Molecular basis of neurometabolic diseases and Development of specific mutation therapies
DRA. BELÉN PÉREZ
Molecular Biology Center
Autonomous University of Madrid
Biología, fisiopatología y terapia de las células satélite del músculo esquelético
DR. JUAN J. VÍLCHEZ PADILLA
Instituto de Investigación Sanitaria
Hospital Universitario y Politécnico La Fe, Valencia
Project We are all weird, We are all unique
The Foundation has been the promoter of a Telemaratón within the project “We are all weird, We are all unique” together with the Federation ASEM and FEDER with the active support of the Ministry of Health, Social Affairs and Equality in the framework of the National Year of Rare Diseases . Through this initiative several calls have also been developed: one of greater amount (75% of the collected) dedicated to finance the investigation with the result of 15 selected projects with a total of 1,456,948 € and two others for the associative movement with 147 beneficiary entities and an amount of € 392,113.
Leave a Reply
Want to join the discussion?Feel free to contribute!